J. Goldman & CO LP Xenon Pharmaceuticals Inc. Transaction History

J. Goldman & CO LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $1.03 Million - $1.2 Million	-30,266 Reduced 63.0%	17,775 $607,000
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $1.67 Million - $2.09 Million	48,041 New	48,041 $1.85 Million
Q4 2017 Feb 14, 2018	SELL	$2.2 - $3.25 $159,280 - $235,300	-72,400 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.25 $177,380 - $235,300	72,400	72,400 $214,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.